Dementia - an innovative treatment with Bacopa monnieri Li

Phase 2

Suspended

• Conditions: Dementia; Mental and Behavioural Disorders; Unspecified dementia

• Registration Number: ISRCTN12595633
• Lead Sponsor: Ambalike Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-22
• Last Update Posted: 4 May 2020
• Study Completion: 2022-12-30

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Aged 18 years and over
2. Diagnosis of dementia

Exclusion Criteria

1. History of intolerance or allergy to Brahmi
2. Type 1 diabetes mellitus
3. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dementia progression measured using the Global Deterioration Scale (GDS) and Standardized Mini-Mental State Examination (SMMSE) at baseline and at the end of 3 months

Secondary Outcome Measures

Name	Time	Method
Age-related falls measured through self-reporting by patients and/or their attendants at baseline and after 1 and 3 months